Analyst Price Target is $7.00
▲ +593.07% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Artelo Biosciences in the last 3 months. The average price target is $7.00, with a high forecast of $7.00 and a low forecast of $7.00. The average price target represents a 593.07% upside from the last price of $1.01.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in Artelo Biosciences. This Buy consensus rating has held steady for over two years.
Artelo Biosciences, Inc. is a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system. The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA.